1Cox JD,Azamia N,Byharrd RW,et al.N2(clinical) non small cell lung cancer:prospective trials of radiation therapy with total dose 60Gy by the RTOG[J].Int J Radiat Oncol Bioi Pyhys,1991,20:7～12.
2Enstrom JE,Austin DF.Interpreting cancer survival rate[J].Science,1977,1:847～851.
4Cox JD,Pajak TF,Asbel AH,et al.Interruption of high-dose radiation therapy decrease long-term survival of favorable with unresectable non-small cell carcinoma of the lung analysis of 1244 case from 3 RTOG trial[J].Int J Radiat Oncol Biol Phys,1993,27:493～498.
6Sause W,Kolesar P,Taylor SIV,et al.Final results of phase Ⅲ trial in regionally advanced resection non- small cell lung cancer:Radiation therapy oncology group [J].Chest,2000,117:358～364.
7Herskovic A,Scottc C,Demas W,et al.Accelerated hyperfractionation for brochogenic cancer:Radiation therapy oncolngy group 9205[J].Am J Clin Oncol,2000,23:207～212.
8Fletcher GH.Clinical dose-response curves of human epithelial tumors[J].Br J Radil,1973,46:1 ～10.
9Craham MV,Purdy JA,Emami B,et al.Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer [J].Int J Radiat Oncol Biol Phys,1995,33 (5):993～1 000.
10Niemnieko A,Goitein M.Modeling of normal tissue response to radiation:the critical volume model [J].Int J Radiat Oncol Phys,1993,25:135 ～145.
二级参考文献34
1蒋国梁 刘泰福.原发性肺癌.现代放射肿瘤治疗学[M].复旦大学出版社,2001.345-346.
2[9]Martel MK. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int Radiat Oncol Biol Phys, 1994,3:575.
3[1]Sause W. Kolesar P, Taylor SIV, et al. Final results of phaseⅢ trial in regionally advanced esectable non-small cell lung cancer: Radiation therapy oncology group, eastern cooperative oncology group, and southwest oncology group.Chest, 2000,117: 358-364.
4[2]Herskovic A, Scottc C, Demas W, et al. Accelerated hyperfractionation for bronchogenic cancer: Radiation therapy oncology group 9205. Am J Clin Oncol,2000,23: 207-212.
5[3]Graham MV, Purdy JA, Emami B, et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys, 1995.5993.
6[4]Krol ADG, Ausses P, Noordijk EM, Hermans J, et al. Local irradiation alone for peripheral stagI lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys, 1996,34:297-302.
7[5]Dubray B. Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. Radiother Oncol, 1995,3: 211.
8[6]Mah K, Van-Dyk J, Keane T, et al. Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys,1987,2:179.
9[7]Armstrong JG. Target volume definition for three-dimensional conformal radiation therapy of lung cancer. Br J Radiol, 1998,71:587.
10[8]Graham MV, Ptrdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 1999,45:1.
